Loading company…
Riskpilot
← Back to search
Sign in
Get full access
HUNNDALEN APOTEK AS
AS
Active
Org 933672425
Raufossvegen 221, 2827 Hunndalen
Retail sale of pharmaceutical products · NACE 4773
Est. 2024
7 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 16,4M
+414% vs 2024
EBITDA margin
3.6%
+436% vs 2024
Equity ratio
15.2%
Financial strength
Net profit 2025
NOK 230K
+183% vs 2024
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
0M
2024
1M
+100%
2025
Key figures
Annual report 2025
Revenue
NOK 16,4M
+414%
EBITDA
NOK 593K
+436%
Net profit
NOK 230K
+183%
Total assets
NOK 4,9M
-8%
Equity
NOK 746K
+45%
Employees
7
—
Company information
Legal name
HUNNDALEN APOTEK AS
Org number
933672425
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
22. juni 2024
Share capital
NOK 800 000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Eie og drive apotek og alt hva hermed står i forbindelse.
Contact
Address
Raufossvegen 221, 2827 Hunndalen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in Gjøvik
All Norway companies
Revenue
NOK millions
0M
5M
9M
14M
18M
3M
2024
16M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2024
1M
2025
Income statement
NOK thousands
Item
2024
2025
Revenue
3 186
16 383
Staff expenses
−744
−2 915
EBITDA
−177
593
Depreciation & amort.
−63
−257
EBIT
−240
336
Net financials
−38
−107
Profit before tax
−278
230
Tax
−0
−0
Net profit
−278
230
Balance sheet
NOK thousands
Item
2024
2025
Total assets
5 343
4 919
Equity
516
746
Long-term debt
2 362
0
Short-term debt
2 464
2 248
Total debt
4 827
4 173
Financial ratios
5-year trend
EBITDA margin
3.6%
This company
15.8%
Market median
-77% vs market
2024
2025
Equity ratio
15.2%
This company
38.2%
Market median
-60% vs market
2024
2025
Return on equity
30.8%
This company
18.4%
Market median
+67% vs market
2024
2025
Net profit margin
1.4%
This company
8.1%
Market median
-83% vs market
2024
2025
Asset turnover
3.33×
This company
1.12×
Market median
+197% vs market
2024
2025
Debt / equity
5.59×
This company
0.62×
Market median
-802% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-05-31 – 2024-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
NG
Natasa Gligoric
Chief Executive Officer
Chief Executive Officer
2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
MF
Morten Frogner
Chairman
2024
JA
Jan Arne Frogner
Board of Directors
2024
EM
Einar Mathias Teigen Rasch-Halvorsen
Board of Directors
2024
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Apotekservice As
Company
25%
25%
2024
Fraunar As
Company
25%
25%
2024
Tr-H As
Company
25%
25%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Fraunar As
HUNNDALEN APOTEK AS
(this company)
Board network connections
Board members of HUNNDALEN APOTEK AS also hold positions in
0
other companies.
Person
Role here
Other companies
Natasa Gligoric
Chief Executive Officer
0 companies
Morten Frogner
Chairman
0 companies
Jan Arne Frogner
Board of Directors
0 companies
Einar Mathias Teigen Rasch-Halvorsen
Board of Directors
0 companies